Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function - Archive ouverte HAL Access content directly
Journal Articles Journal of Cystic Fibrosis Year : 2020

Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function

Pierre-Régis Burgel
Isabelle Durieu
  • Function : Author
Raphaël Chiron
  • Function : Author
Laurent Mely
  • Function : Author
Anne Prevotat
  • Function : Author
Marlene Murris-Espin
  • Function : Author
Michele Porzio
  • Function : Author
Philippe Reix
Christophe Marguet
  • Function : Author
Julie Macey
  • Function : Author
Isabelle Sermet-Gaudelus
Harriet Corvol
Stéphanie Bui
  • Function : Author
Tiphaine Biouhee
  • Function : Author
Dominique Hubert
  • Function : Author
Anne Munck
  • Function : Author
Lydie Lemonnier
  • Function : Author
Clémence Dehillotte
  • Function : Author
Jennifer Da Silva
  • Function : Author
Jean-Louis Paillasseur
  • Function : Author
Clémence Martin

Dates and versions

hal-03048559 , version 1 (09-12-2020)

Identifiers

Cite

Pierre-Régis Burgel, Isabelle Durieu, Raphaël Chiron, Laurent Mely, Anne Prevotat, et al.. Clinical response to lumacaftor-ivacaftor in patients with cystic fibrosis according to baseline lung function. Journal of Cystic Fibrosis, 2020, ⟨10.1016/j.jcf.2020.06.012⟩. ⟨hal-03048559⟩

Collections

URCA P3CELL
20 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More